No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home Stock

Swiss Formula Condemns Injust Moves by Britain’s Veterinary Medicines Directorate (VMD)

by
September 7, 2023
in Stock
0
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Formula Swiss, a leading Swiss CBD company founded in 2013, has raised concerns over the recent actions taken by the Veterinary Medicines Directorate (VMD) in the United Kingdom. The VMD has been stopping shipments of their products to customers, claiming they are “unauthorized veterinary medicines,” despite the fact that these products are fully legal and registered in the UK.

CEO of Formula Swiss, Robin Roy Krigslund-Hansen said, “Our products are clearly described and registered for topical usage, not for veterinary medicine. The actions of the VMD are not only incorrect but also damaging to our brand and our loyal customer base.”

One such product is Formula Swiss Raw CBD Oil Drops in Hemp Seed Oil 500 mg, 0.2% THC, which has been correctly registered in the Submit Cosmetic Product Notifications portal with the UK cosmetic product number UKCP-81209741 since 2021.

Formula Swiss is now considering taking legal action to stop the VMD from further wrongdoings and any potential damage to their brand. They urge the VMD to correct their errors immediately to prevent unnecessary legal actions and to uphold the integrity of regulatory bodies.

Commenting on the situation, Krigslund-Hansen said “The VMD’s actions are absurd and frustrating. We urge them to rectify the situation immediately.”

Formula Swiss, a leading Swiss CBD company founded in 2013, has raised serious concerns over the recent actions of the Veterinary Medicines Directorate (VMD) in the United Kingdom. The VMD has been stopping shipments of Formula Swiss products, claiming they are “unauthorized veterinary medicines,” despite these products being fully legal and registered in the UK.

One such product is Formula Swiss Raw CBD Oil Drops in Hemp Seed Oil 500 mg, 0.2% THC, which has been correctly registered in the Submit Cosmetic Product Notifications portal with the UK cosmetic product number UKCP-81209741 since 2021.

CEO of Formula Swiss, Robin Roy Krigslund-Hansen commented, “Our products are clearly described and registered for topical usage, not for veterinary medicine. The actions of the VMD are not only incorrect but also damaging to our brand and our loyal customer base.”

In light of the VMD’s actions, Formula Swiss is now considering taking legal action to stop them from further wrongdoings and any potential damage to their brand. Krigslund-Hansen added, “The VMD’s actions are absurd and frustrating. We urge them to rectify the situation immediately.”

Formula Swiss is calling on the VMD to correct their errors immediately to prevent unnecessary legal actions and to uphold the integrity of regulatory bodies.

The post Swiss Formula Condemns Injust Moves by Britain’s Veterinary Medicines Directorate (VMD) first appeared on BusinessMole.

Previous Post

Behind the Numbers: Debunking Myths about Purchased Instagram Followers

Next Post

Conservation Efforts to Reverse Decline of Capercaillie Not Enough to Prevent Extinction

Next Post

Conservation Efforts to Reverse Decline of Capercaillie Not Enough to Prevent Extinction

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024
Idaho Bucks Managed Care Trend

Idaho Bucks Managed Care Trend

December 5, 2023

Last Day to Give in 2023!

December 31, 2023

The Producer Price Index

September 9, 2023

How Trump Can Lower Drug Prices Without Price Controls

0

0

0

0

How Trump Can Lower Drug Prices Without Price Controls

May 14, 2025
From Dog Leashes to Potty Breaks: Are We All Unwitting Criminals?

From Dog Leashes to Potty Breaks: Are We All Unwitting Criminals?

May 14, 2025

British Motor Yacht Show 2025 Opens, Defying Downturn with £1.4bn Boost to UK Marine Sector

May 14, 2025
Congress Set to Boost Federal Debt $5 Trillion

Congress Set to Boost Federal Debt $5 Trillion

May 14, 2025

Recent News

How Trump Can Lower Drug Prices Without Price Controls

May 14, 2025
From Dog Leashes to Potty Breaks: Are We All Unwitting Criminals?

From Dog Leashes to Potty Breaks: Are We All Unwitting Criminals?

May 14, 2025

British Motor Yacht Show 2025 Opens, Defying Downturn with £1.4bn Boost to UK Marine Sector

May 14, 2025
Congress Set to Boost Federal Debt $5 Trillion

Congress Set to Boost Federal Debt $5 Trillion

May 14, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.